The strain BALB/cHeA (BALB/c) is a high producer, and STS/A (STS) a low producer of IgE after Leishmania major infection. We analyzed this strain difference using 20 recombinant congenic (RC) BALB/c-c-STS/Dem (CcS
Introduction
Immunoglobulin E (IgE) and its receptors are believed to have evolved as a mechanism to protect mammals against parasites, namely the helminth infections. 1 However, some apparently innocuous antigens can subvert this system to provoke an allergic response. 2 IgE response is controlled by a complex network of molecular interactions that includes IgE, low and high affinity receptors for IgE (Fc⑀RI and Fc⑀RII, respectively), integrins CD11b/CD11c, ⑀-binding proteins (⑀BP), complement receptor CR2, cytokines and hormones. 2, 3 At least two signals are necessary for the induction of IgE production: either interleukin (IL)-4 or IL-13 and CD40/CD40L pairing. A pathway independent of CD40L which is mediated via CD30L and requires IL-4 and IL-5 to induce IgE production was also described. 4 IL-5, IL-6, IL-9 and TNF␣ augment IgE expression, whereas interferon (IFN)␥, IFN␣, IL-8, IL-10, IL-12 and PGE2 inhibit this process (reviewed in Romagnani 5 ). IgE receptors Fc⑀RI and Fc⑀RII (CD23) influence IgE level by a feedback mechanism.
2 Obviously, the observed IgE level would be the result of interrelationship of all these multiple known factors and perhaps some unknown factors as well.
Several loci determining genetic control of IgE level in humans have been described, 6 but there are considerable differences between results obtained in different studies. 7 One of the reasons for these discrepancies may be the definition of phenotype, but there are other factors that make analysis of multigenically regulated diseases in humans difficult, and which include genetic heterogeneity of human populations, gene interactions, high frequency and/or incomplete penentrance of diseasecausing alleles and a great complexity of environmental factors. These limitations are especially important in the cases where there are large numbers of segregating disease loci. As different genotypes can conceivably lead to the same phenotype, the same disease in different families could be controlled by different genes. 8 Some of these problems could be overcome by the use of a mouse model. As a model for study of complex genetic regulation of IgE production we used the response to infection of Leishmania major in mouse. L. major is a protozoan parasite that infects mononuclear phagocytes of vertebrate host. In most mouse strains this infection causes no or only transient pathological changes, whereas some strains develop systemic visceral disease with skin lesions, splenomegaly, hepatomegaly, anemia, cytokine imbalance and increased serum IgE. 9 The susceptible strain BALB/cHeA (BALB/c) exhibits a high, whereas the resistant strain STS/A (STS) a low serum IgE level after L. major infection. 10 We have analyzed the genetic basis of this strain difference using the recombinant congenic (RC) strains of the BALB/c-c-STS/Dem (CcS/Dem) series. This series comprises 20 homozygous strains all derived from two parental inbred strains: the 'background' strain BALB/c and the 'donor' strain STS. Each CcS/Dem strain contains a different, random set of approximately 12.5% genes of the donor strain STS and approximately 87.5% genes of the background strain BALB/c. 11 In this way, the STS genes controlling the IgE production became separated into individual CcS/Dem strains. In our previous studies we have selected the most resistant RC strain CcS-5 12 and identified two loci that control IgE after L. major infection, Leishmania major response 3 (Lmr3) and Lmr5 on chromosomes 5 and 10, respectively. 10 Interestingly, Lmr5 maps to the segment of mouse chromosome 10, homologous with human region 12q15-q24.1, which controls total IgE concentrations in humans. 13 In the present study we have analyzed the control of IgE production in low and high producing strains CcS-20 and -16, respectively.
Results

Strain differences in serum IgE levels in recombinant congenic strains
We measured levels of total serum IgE after 8 weeks of L. major infection in 305 female mice of BALB/c, STS and 20 CcS/Dem RC strains. The results are given in Figure  1 . The background parental strain BALB/c produces high and the donor strain STS low IgE levels (mean IgE levels in non-infected BALB/c and STS mice were 1.00 ± 0.36 and 0.28 ± 0.16 g/ml (P Ͻ 0.03), infected BALB/c and STS produced 14.13 ± 2.24 and 0.34 ± 0.07 g/ml (P Ͻ 0.000007), respectively). Non-infected CcS/Dem strains exhibited lower mean IgE production than BALB/c, but the differences were not significant. Eleven RC strains CcS-1, -2, -5, -6, -7, -9, -10, -13, -15, -17, -20 exhibited lower IgE levels than the background strain BALB/c after L. major infection, the lowest IgE levels being observed in the strain CcS-5 (P Ͻ 2.87 × 10
−38
). The low producers CcS-5 and -20 and a high producer CcS-16 were selected for further investigation. Genetic analysis of IgE production in CcS-5 was described elsewhere, 10 control of IgE production in CcS-16 and -20 has been analyzed in this study.
Genetic control of IgE production in F 2 hybrids between BALB/c and CcS- 16 Statistical evaluation of linkage of the IgE production in 578 F 2 hybrids between BALB/c and CcS-16 is given in Figure 2 ). We also detected four additional novel loci: Lmr8 near to the markers D1Mit14, D1Mit227 and D1Mit17 on chromosome 1 (corr. P Ͻ 0.0000557, 0.00157 and 0.0209, respectively), Lmr9 near the marker D4Mit149 on chromosome 4 (corr. P Ͻ 0.00313), and to Lmr10 near the markers D8Mit125 and D8Mit54 (corr. P Ͻ 0.000731 and 0.0000111, respectively). Lmr11 is marked by D3Mit11 and D3Mit25 and it does not influence the IgE level independently but interacts with Lmr8 on chromosome 1 (corr. P Ͻ 0.0229 and 0.00522, respectively). BALB/c alleles of Lmr8, 9 and 10 are associated with high IgE levels, whereas STS alleles of these loci determine low IgE levels (Table 2a) . BALB/c alleles of Lmr8 (D1Mit14) and Lmr11 (D3Mit11 and D3Mit25) interact in determining IgE levels, lower levels being observed in interaction of BALB/c and STS homozygotes in Lmr11 and Lmr8, respectively (Table 2b) . Influence of the experimental group was apparent (P Ͻ 0.0001-0.0003), but no significant interaction between experimental group and linkage was observed. No effect of age was found on any linkage.
Discussion
We have studied the strain difference in L. major-induced serum IgE levels between BALB/c and STS using the 20 RC strains of CcS/Dem series. If the difference in IgE expression between BALB/c and STS was controlled by an additive effect of a very large number of non-linked loci, each CcS strain would likely receive at least some of them from the donor strain, and hence most of all CcS strains would exhibit a similar, intermediate response.
However the large differences between individual CcS strains and the number of high-and low-responder strains ( Figure 1 ) suggest that a relatively limited number of genes is involved in the control of IgE level in serum. This was indeed the case when three CcS/Dem strains, CcS-5, -16 and -20 were selected and genetically analyzed. In our previous studies we have identified two loci that control IgE level in the strain CcS-5, Lmr3 and Lmr5 on chromosomes 5 and 10, respectively. 10 In the present paper we describe seven additional loci that control IgE level in the strains CcS-16 and -20. The information about all nine loci is summarized in Table 3 .
We found in the strain CcS-16, despite the similarity of its IgE levels to BALB/c, four loci controlling IgE level on chromosomes 2, 10, 16 and 18 (Tables 1a, b and 3, Figure 2 ). The region on chromosome 10 overlaps with the locus Lmr5 that we have mapped in the cross between BALB/c and CcS-5. In the strain CcS-5 Lmr5 is situated on the STS-derived segment with the maximal length 28 cM, containing candidate genes Ifng (interferon ␥) and Stat6 (signal transducer and activator of transcription 6) (http://www.informatics.jax.org). Both of them have been reported to influence IgE level. 14, 15 Maximal length of the STS-derived region in CcS-16 is 3 cM and it contains Stat6 but not Ifng. It is therefore possible that two linked loci on chromosome 10 control the IgE levels in infected mice: Lmr5 in the vicinity of Ifng and a more telomerically located gene. This part of mouse chromosome 10 is homologous with the long arm of human chromosome 12, which was reported to control total serum IgE.
13 Lmr12 marked by D16Mit126 is localized in the central region of chromosome 16 with the maximal length 6 cM and contains no obvious candidate genes. We have mapped to this segment the locus Cypr1 (Cytokine production 1) that controls IL-4 production. 16 IL-4 is a strong inducer of IgE. 5, 14 CcS-16 carries on chromosome 18 an STS-derived segment with the maximal length 30 cM. Lmr13 maps to the central part of this segment, in the proximity of genes csf1r (colony stimulating factor 1 receptor), Cd14 (CD14 antigen) and Adrb2 (adrenergic receptor, beta 2) that were shown to influence IgE level.
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CSF or stimulation of ␤2 adrenergic receptor led to increase of IgE level, 17, 18 whereas CD14 engagement inhibits the IgE synthesis. 19 Lmr13 is situated in the part of mouse chromosome 18 that is homologous with the human segment 5q31-q33 known to be involved in the control of atopy and defense against pathogens. Both polymorphism in the 5Ј flanking region of the human CD14 on chromosome 5q31.1 and in ␤2 adrenergic receptor were shown to be associated with total serum IgE. 20, 21 Locus SM1 in the region 5q31-q33 determines the intensity of infection by Schistosoma mansoni 22 and may also influence blood level of Plasmodium falciparum. 23 IgE plays an important role in the response to helminth infections 1 and therefore it cannot be excluded that responses controlled by Lmr13 and SM1 are influenced by the same (homologous) gene. Lmr14 is localized on central part of chromosome 2 that contains no obvious candidate genes.
IgE production in CcS-20 is controlled by five loci on chromosomes 1, 3, 4, 5 and 8 (Tables 2a, b Figure  2 ). The locus on chromosome 5 overlaps with Lmr3 that controls IgE production in CcS-5. CcS-20 carries on chromosome 5 three STS derived segments. Lmr3 maps to the centromeric region with the maximal length 33 cM. No obvious candidate genes are localized in this region. We have mapped to this segment the locus Cypr3 that controls IL-10 production.
16 IL-10 was described to inhibit IL-4-induced IgE synthesis. 24 Interestingly, Tir2 (Trypanosoma infection response 2) also maps to this region.
25
Lmr8 maps to the two STS derived segments on the distal part of chromosome 1, with the maximal length 8.2 and 7.1 cM, respectively. The more distal of them contains no obvious candidate genes, whereas in the segment near the marker D1Mit14 Tnfsf4 (tumor necrosis factor superfamily, member4) and Tnfsf6 (formerly Fasl) are localized 26 and inhibits IgE production. 27 Importance of this chromosomal region for defense against infection is stressed by the fact that other loci, which control response to different pathogenic organisms, map to this segment: Rpm4 (resistance to mouse pox 4) and Tir3 (Trypanosoma infection response 3) (http://www.informatics.jax.org). To the BALB/c segment in the vicinity of this region Trl-1 (Tuberculosis resistance locus 1) 28 also maps. We have also mapped to this segment the locus Cypr2, which controls mitogen-induced IL-10 production.
16 Lmr9 maps to the centromeric part of chromosome 4, with the maximal length 1.9 cM, where there is no obvious candidate gene. Lmr10 maps to the proximal and central part of chromosome 8 with the maximal length 16 cM. In this region Scvr (scavenger receptor) and Casp3 (caspase 3) are found that are involved in apoptotic reactions induced by intracellular pathogens. 26 Lmr11 is localized on the central part of chromosome 3 with the maximal length 41.2 cM. In this segment are two candidate genes, il12a (interleukin 12a) and il6ra (interleukin 6 receptor, alpha) (http://www.informatics.jax.org). IL-12 suppresses IgE production via IFN␥, 29 whereas IL-6 can potentiate it. 30 We have shown previously that the loci Lmr3 and Lmr5 that control IgE production in CcS-5 also influence other pathological and immunological parameters. Lmr3 determines splenomegaly, hepatomegaly and IFN␥ level in serum, whereas Lmr5 controls lesion size, splenomegaly and levels of IL-2 and IFN␥ in serum. 10 Similar phenomena have also been observed in CcS-16 and CcS-20. All IgE controlling loci, except Lmr9 and Lmr12, influence development of cutaneous and/or visceral leishmaniasis (Vladimirov et al, submitted) . The question whether this reflects a causative relationship and whether these parameters are controlled by a single gene or by a complex of two or more linked genes needs to be solved by recombinant mapping.
We have analyzed three RC strains that cover approximately 35% of differences between BALB/c and STS. These differences are controlled by nine genetic loci. Despite the overall genetic similarity between the strains CcS-5, -16 and -20 (each has 87.5% of the BALB/c genome), only two loci control IgE level in more than one strain. This finding resembles the situation observed in studies of human atopy where linkage observed in one population is not seen in the other population, sometimes from the same country. 7 RC strains might therefore serve as a model of these different human families. Their analysis could help both to identify IgE controlling genes and to elucidate interactions between different alleles in diseases caused by disregulation of IgE production.
Materials and methods
Mice
Females of strains BALB/c, STS and RCS of CcS/Dem series 8 to 26 weeks old at the time of infection, were from the breeding colony of P. Demant. When used for these experiments, the RCS were in the generation 28 of inbreeding and therefore highly homozygous. The parts of RCSЈ genomes inherited from the BALB/c or STS parents were defined. 31 Female F 2 hybrids between CcS-16 and BALB/c (age 14 to 17 weeks at the time of infection)
Genes and Immunity and CcS-20 and BALB/c (age 9 to 14 weeks) were produced at the Institute of Molecular Genetics. Each cross was tested in four independent experimental groups. Parasites L. major LV 561 (MHOM/IL/67/LRC-L137 JERICHO II) was maintained in rump lesions of BALB/c females. Amastigotes were transformed to promastigotes using SNB-9. 32 10 7 promastigotes from 6 days old subculture 2 were inoculated in 50 l sterile saline s.c. into mouse rump.
IgE levels
IgE levels in serum were determined using the primary and secondary monoclonal antibodies R3572 and R3592, Table 2 (a) Linkage of the IgE production in F 2 hybrids between CcS-20 and BALB/c. In order to normalize the distribution of the observed IgE levels required for ANOVA, 1 was added to the decadic logarithm of the measured values and the values were transformed to the power of 0.3. The tables give both the IgE levels in g/ml attributed by ANOVA to individual genotypes as well as (in italics) the means ± s.e. of the transformed values computed by ANOVA. C and S indicate the presence of BALB/c and STS allele, respectively. NS, not significant, is used for P Ͼ 0. respectively, and standard IgE3 from Pharmingen (San Diego, CA, USA). The ELISA was performed as recommended by Pharmingen. The IgE levels were estimated using the curve fitter program KIM-E.
Genotyping of simple sequence length polymorphism (SSLP) by PCR DNA was isolated from tails using a standard proteinase procedure. The strains CcS-16 and CcS-20 differ from
Genes and Immunity BALB/c at STS derived segments on nine and 10 chromosomes, respectively. 31 These differential segments were typed in the F 2 hybrid mice between CcS-16 and BALB/c using 23 microsatellite markers (Research Genetics, Huntsville, FL, USA): D2Mit156, D2Mit389, D2Mit102, D2Nds3, D2Mit283, D2Mit51, D3Mit25, D3Mit11, D4Mit153, D6Mit48, D6Mit320, D10Mit67, D10Mit103, D11Mit139, D11Mit242, D11Mit37, D16Mit126, D17Mit38, D17Mit130, D18Mit120, D18Mit35, D18Mit40 and D18Mit49. For the analysis of the F 2 hybrids between CcS-20 and BALB/c 26 markers were used: D1Mit14, D1Mit227, D1Mit17, D2Mit52, D2Mit148, D2Mit74, D3Mit25, D3Mit49, D3Mit11, D4Mit149, D5Mit55, D5Mit114, D5Mit175, D5Mit63, D5Mit143, D6Mit52, D6Mit58, D8Mit125, D8Mit54, D9Mit90, D9Mit2, D14Mit129, D14Mit170, D16Mit15, D16Mit19, D16Mit94. The maximum distance between any two markers in the chromosomal segments derived from the strain STS or from the nearest BALB/c derived markers was 20 cM. The PCR genotyping was performed as described elsewhere. 33 
Statistical analysis
The differences between CcS/Dem strains were evaluated by analysis of variance and Newman-Keuls multiple comparison test (ANOVA, NCSS). Strain and age were fixed factors and individual experiments were considered as a random parameter. In order to obtain normal distribution of the observed IgE levels required for ANOVA, the measured values were transformed to the power of 0.5. The differences between strains were evaluated by Newman-Keuls multiple comparison test.
The role of genetic factors in control of IgE level was examined by analysis of variance (ANOVA, NCSS). Marker, gender and age were fixed factors and the experiment was considered a random parameter. In order to obtain normal distribution required for ANOVA, the obtained values were transformed as shown in the legend of Table 2 . Markers and interactions with P Ͻ 0.05 were combined in a single comparison. To obtain whole genome significance values (corrected P) the observed Pvalues (␣ T ) were adjusted according to Lander and Kruglyak 34 using the formula: 
